Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merit Medical Systems (MMSI) EBIT (2016 - 2025)

Merit Medical Systems' EBIT history spans 16 years, with the latest figure at -$94.6 million for Q4 2025.

  • For Q4 2025, EBIT fell 358.8% year-over-year to -$94.6 million; the TTM value through Dec 2025 reached $35.9 million, down 76.94%, while the annual FY2025 figure was $35.9 million, 76.94% down from the prior year.
  • EBIT for Q4 2025 was -$94.6 million at Merit Medical Systems, down from $42.6 million in the prior quarter.
  • Across five years, EBIT topped out at $46.9 million in Q2 2025 and bottomed at -$94.6 million in Q4 2025.
  • The 5-year median for EBIT is $24.8 million (2022), against an average of $12.2 million.
  • The largest annual shift saw EBIT surged 24792.19% in 2021 before it crashed 358.8% in 2025.
  • A 5-year view of EBIT shows it stood at -$27.7 million in 2021, then tumbled by 43.68% to -$39.8 million in 2022, then crashed by 67.85% to -$66.8 million in 2023, then skyrocketed by 154.74% to $36.6 million in 2024, then plummeted by 358.8% to -$94.6 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's EBIT are -$94.6 million (Q4 2025), $42.6 million (Q3 2025), and $46.9 million (Q2 2025).